X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
central-nervous-system (5) 5
humans (5) 5
male (5) 5
combined modality therapy (4) 4
index medicus (4) 4
medicine & public health (4) 4
middle aged (4) 4
oncology (4) 4
whole-brain radiotherapy (4) 4
adult (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
central nervous system neoplasms - therapy (3) 3
follow-up studies (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
prognosis (3) 3
stem-cell transplantation (3) 3
1st-line treatment (2) 2
anaplastic oligodendroglioma (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
brain neoplasms - radiotherapy (2) 2
central nervous system neoplasms - diagnosis (2) 2
central nervous system neoplasms - mortality (2) 2
disease progression (2) 2
disease-free survival (2) 2
follow-up (2) 2
high-dose chemotherapy (2) 2
intensive chemotherapy (2) 2
multicenter phase-ii (2) 2
neoplasm staging (2) 2
non-hodgkins-lymphoma (2) 2
oligodendroglioma - radiotherapy (2) 2
pcv chemotherapy (2) 2
prospective studies (2) 2
radiation-therapy (2) 2
radiotherapy (2) 2
radiotherapy, adjuvant (2) 2
response criteria (2) 2
survival rate (2) 2
treatment outcome (2) 2
tumors (2) 2
young adult (2) 2
activated microglia (1) 1
acute kidney injury - chemically induced (1) 1
adjuvant chemotherapy (1) 1
adolescent (1) 1
aged (1) 1
amyloid beta-protein (1) 1
anaplastic astrocytoma (1) 1
anaplastic oligoastrocytoma (1) 1
anemia - chemically induced (1) 1
animals (1) 1
astrocytoma - drug therapy (1) 1
astrocytoma - radiotherapy (1) 1
astrocytoma - surgery (1) 1
astrocytoma - therapy (1) 1
base sequence (1) 1
biochemistry (1) 1
biochemistry & molecular biology (1) 1
biophysics (1) 1
biopsy (1) 1
brachytherapy - methods (1) 1
brain - cytology (1) 1
brain - metabolism (1) 1
brain - parasitology (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - mortality (1) 1
brain neoplasms - surgery (1) 1
brain neoplasms - therapy (1) 1
cancer and oncology (1) 1
cancer och onkologi (1) 1
carmustine - administration & dosage (1) 1
ccnu (1) 1
cd4+ t-cells (1) 1
cell biology (1) 1
center experience (1) 1
central nervous system neoplasms - diagnostic imaging (1) 1
central nervous system neoplasms - immunology (1) 1
ceramide (1) 1
cerebrospinal-fluid (1) 1
chemical and drug induced liver injury - epidemiology (1) 1
chemotherapy (1) 1
chemotherapy, adjuvant (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
class-ii antigens (1) 1
clinical medicine (1) 1
clinical neurology (1) 1
clinical-trials (1) 1
cohort studies (1) 1
combined modality therapy - adverse effects (1) 1
combined modality therapy - methods (1) 1
comparative effectiveness research (1) 1
cytarabine - adverse effects (1) 1
cytarabine - therapeutic use (1) 1
cytokines - biosynthesis (1) 1
cytokines - genetics (1) 1
death, sudden - epidemiology (1) 1
denmark (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. e322 - e332
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 8, pp. e388 - e397
Journal Article
medizinische genetik, ISSN 0936-5931, 12/2016, Volume 28, Issue 4, pp. 424 - 434
Epigenetische Regulationsmechanismen sind essenziell für den koordinierten Ablauf zahlreicher zellulärer Prozesse wie die Differenzierung und Entwicklung oder... 
Human Genetics | Pediatrics | Epigenetik | Medicine & Public Health | MGMT | Obstetrics/Perinatology | Tumorepigenom | Epigenetics | DNA methylation | DNA-Methylierung | Reproductive Medicine | Tumor epigenome
Journal Article
DEUTSCHES ARZTEBLATT INTERNATIONAL, ISSN 1866-0452, 06/2018, Volume 115, Issue 25, pp. 419 - 419
Background: Primary central nervous system lymphoma is a diffuse large B-cell lymphoma with exclusive manifestation in the central nervous system (CNS),... 
MEDICINE, GENERAL & INTERNAL | DIFFERENTIAL-DIAGNOSIS | INTENSIVE CHEMOTHERAPY | MULTICENTER PHASE-II | IMMUNOCOMPETENT PATIENTS | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | INTERNATIONAL EXTRANODAL LYMPHOMA
Journal Article
Journal Article
Journal of Neuropathology and Experimental Neurology, ISSN 0022-3069, 03/2009, Volume 68, Issue 3, p. 286
  Neuropathologic and biochemical findings in a 34-year-old man whose disease began 2 years before death appearing as chronic progressive encephalitis and... 
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 2008, Volume 173, Issue 1, pp. 93 - 105
The pathogenesis of inflammatory autoimmune diseases of the peripheral nervous system, leading to demyelination and/or axonal damage, remains incompletely... 
Journal Article
best practice onkologie, ISSN 0946-4565, 2/2010, Volume 5, Issue 1, pp. 26 - 35
Primäre ZNS-Lymphome sind in meist aggressive, rasch wachsende Non-Hodgkin-Lymphome vom B-Zell-Typ. Die Diagnostik erfolgt mittels zerebraler... 
Pain Medicine | Medicine & Public Health | Hematology | Gynecology | Internal Medicine | Oncology | Surgical Oncology
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 9/2002, Volume 59, Issue 3, pp. 231 - 237
The time to tumor progression (TTP), time to death (TTD) and complications were studied prospectively in a cohort of patients treated by surgery and adjuvant... 
anaplastic oligoastrocytoma | Medicine & Public Health | radiation | anaplastic astrocytoma | Oncology | PCV chemotherapy | anaplastic oligodendroglioma | surgery | Anaplastic oligoastrocytoma | Surgery | Anaplastic astrocytoma | Anaplastic oligodendroglioma | Radiation | ADJUVANT CHEMOTHERAPY | VINCRISTINE PCV | LOMUSTINE | PHASE-II | PROCARBAZINE | CLINICAL NEUROLOGY | MALIGNANT GLIOMA | ONCOLOGY | CCNU | Astrocytoma - radiotherapy | Oligodendroglioma - surgery | Prospective Studies | Astrocytoma - therapy | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Oligodendroglioma - radiotherapy | Brain Neoplasms - surgery | Taxoids | Vinblastine - analogs & derivatives | Vinblastine - adverse effects | Astrocytoma - drug therapy | Adult | Female | Brain Neoplasms - radiotherapy | Oligodendroglioma - drug therapy | World Health Organization | Paclitaxel - adverse effects | Survival Rate | Treatment Outcome | Combined Modality Therapy | Brain Neoplasms - drug therapy | Radiotherapy | Paclitaxel - therapeutic use | Disease Progression | Oligodendroglioma - therapy | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hematologic Diseases - etiology | Brain Neoplasms - therapy | Cisplatin - adverse effects | Neoplasm Staging | Astrocytoma - surgery | Cohort Studies
Journal Article
BBA - Biomembranes, ISSN 0005-2736, 2006, Volume 1758, Issue 12, pp. 1978 - 1994
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.